CD4 + memory T cells can release some anti-tumor molecules such as IFN-γ, TNF-α, and Granzyme B. Therefore, a high frequency of these cells in the TME is associated with better survival of patients with cancer [220, 221]. This evidence concerns the gene IFNG and neoplasm.